Celia Lin - 13 May 2021 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Chief Medical Officer
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol
VERA
Transactions as of
13 May 2021
Net transactions value
$0
Form type
4
Filing time
17 May 2021, 20:33:26 UTC
Next filing
18 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Stock Option (right to buy) Award $0 +16,916 $0.000000 16,916 13 May 2021 Class A Common Stock 16,916 $11.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option vest on May 13, 2022, and 1/48 of the shares vest monthly thereafter.